Will Ashworth

Will Ashworth

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

The Pros and Cons for Buying Social Capital Hedosophia Holdings V as the Merger Approaches

Social Capital Hedosophia Holdings V took 91 days to announce it was merging with SoFi. Does a quick courting period bode well for IPOE stock? 

Under $1, Naked Brand Group Is Trading Where It Belongs

Naked Brand Group is back trading below $1 where it belongs. It’s time for investors to move on from NAKD stock.

Can Carnival Stock Get Back to $72.70 by the End of 2022?

Carnival rose 43% in the month of February. Can CCL stock get back to its all-time highs by the end of 2022?

Does Workhorse Group’s Hail Mary Have a Shot?

Investors who bought Workhorse in the $40s are praying company’s meeting with USPS went well. Will Workhorse’s Hail Mary save WKHS stock?

An ETF to Hold Dogecoin and Other Cryptocurrencies Would Be Ideal

InvestorPlace’s Mark Hake likes Dogecoin as an alternative cryptocurrency. There's a need for ETF that holds all the major cryptocurrencies.

7 of the Best Warren Buffett Stock Picks of the Past Decade

It's very tough to figure out which of Warren Buffett's holdings represent the best stocks he's bought the past decade. Here are seven.

10 Stocks to Buy With $1,000

Now that fractional shares are an option at most online brokers, finding 10 stocks to buy for $1,000 for average investors is simple to do.  

Aurora Cannabis’ Altman Z-Score Suggests Investors Look Elsewhere

Aurora Cannabis has an Altman Z-Score of -1.71. That means it could go bankrupt. That’s not good news for owners of ACB stock. 

Is Jaguar Health Ready to Bounce Back From a Lousy February?

Jaguar Health did not have a good February. Down 25% through Feb. 25, it might be time to give up on JAGX stock despite SPAC spinoff.

Should SunPower Be in Your Portfolio of Sun Stocks?

SunPower is one of the “sun stocks" Wall Street finds attractive in 2021. Should you buy SPWR stock on its own or as part of a portfolio?